These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7948634)

  • 21. Hydroxyapatite ceramics for continuous delivery of heparin.
    Abrams L; Bajpai PK
    Biomed Sci Instrum; 1994; 30():169-74. PubMed ID: 7948632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibiotic release by tricalcic phosphate bone implantation. In vitro and in vivo pharmacokinetics of different galenic forms].
    Thomazeau H; Langlais F
    Chirurgie; 1997 Jan; 121(9-10):663-6. PubMed ID: 9138328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interrelationship between buffer systems and particle sizes of TCPL drug delivery system.
    Apple MJ; Benghuzzi H; Parsell D; England B
    Biomed Sci Instrum; 1996; 32():47-53. PubMed ID: 8672689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone regeneration of porous beta-tricalcium phosphate (Conduit TCP) and of biphasic calcium phosphate ceramic (Biosel) in trabecular defects in sheep.
    Bodde EW; Wolke JG; Kowalski RS; Jansen JA
    J Biomed Mater Res A; 2007 Sep; 82(3):711-22. PubMed ID: 17326225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porosity and pore size of beta-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study.
    Kasten P; Beyen I; Niemeyer P; Luginbühl R; Bohner M; Richter W
    Acta Biomater; 2008 Nov; 4(6):1904-15. PubMed ID: 18571999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A ceramic system for delivering interleukin-2.
    Smith SW; Billotte WG; Krane D; Sage K; Bajpai PK
    Biomed Sci Instrum; 1997; 34():65-9. PubMed ID: 9603014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apatite formation on three kinds of bioactive material at an early stage in vivo: a comparative study by transmission electron microscopy.
    Neo M; Nakamura T; Ohtsuki C; Kokubo T; Yamamuro T
    J Biomed Mater Res; 1993 Aug; 27(8):999-1006. PubMed ID: 8408128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of HA, TCP and ALCAP bioceramic capsules on the viability of human monocyte and monocyte derived macrophages.
    Ross L; Benghuzzi H; Tucci M; Callender M; Cason Z; Spence L
    Biomed Sci Instrum; 1996; 32():71-9. PubMed ID: 8672693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The physiological response associated with large particles of TCP, HA, and ALCAP implants using raw 264.7 cells.
    Thorns M; Benghuzzi H; Tucci M; Cason Z
    Biomed Sci Instrum; 2001; 37():287-92. PubMed ID: 11347404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biodegradable gentamicin-depot implants made of beta-tricalcium phosphate ceramics. 3. In vivo studies on drug release, tissue tolerance, and biodegradation].
    Thoma K; Alex R; Randzio J
    Pharmazie; 1991 Apr; 46(4):266-70. PubMed ID: 1715996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of spermatogenesis by means of continuous delivery of danazol in combination with dihydrotestosterone from ALCAP drug delivery devices.
    Benghuzzi HA; Bajpai PK; England BG
    Biomed Sci Instrum; 1990; 26():141-9. PubMed ID: 2334758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review paper: behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition.
    Kamitakahara M; Ohtsuki C; Miyazaki T
    J Biomater Appl; 2008 Nov; 23(3):197-212. PubMed ID: 18996965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of TiO2 and Ag2O addition on tricalcium phosphate ceramics.
    Seeley Z; Bandyopadhyay A; Bose S
    J Biomed Mater Res A; 2007 Jul; 82(1):113-21. PubMed ID: 17269142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of tobramycin release from beta tricalcium phosphate drug delivery system.
    Aneja A; Woodall J; Wingerter S; Tucci M; Benghuzzi H
    Biomed Sci Instrum; 2008; 44():88-93. PubMed ID: 19141898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs.
    Urist MR; Nilsson O; Rasmussen J; Hirota W; Lovell T; Schmalzreid T; Finerman GA
    Clin Orthop Relat Res; 1987 Jan; (214):295-304. PubMed ID: 3791755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
    Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
    Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a hydroxyapatite ceramic matrix for the continuous delivery of coumadin.
    Mileti IF; Bajpai PK
    Biomed Sci Instrum; 1995; 31():177-82. PubMed ID: 7654958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative performance of three ceramic bone graft substitutes.
    Hing KA; Wilson LF; Buckland T
    Spine J; 2007; 7(4):475-90. PubMed ID: 17630146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autoradiographic study of calcium phosphate ceramic bone implants in turkeys.
    Metsger DS; DePhilip RM; Hayes TG
    Clin Orthop Relat Res; 1993 Jun; (291):283-94. PubMed ID: 8389263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.